首页> PloS one> Clinical benefit of cancer drugs approved in Switzerland 2010-2019.

Clinical benefit of cancer drugs approved in Switzerland 2010-2019.

导出 OA

翻译打印收藏纠错

第一作者： Roman,Adam

第一单位： Faculty of Medicine, University of Basel, Basel, Switzerland.

作者： Roman,Adam ^[1] ; Ariadna,Tibau ^[2] ; Consolación,Molto Valiente ^[2] ; Boštjan,Šeruga ^[3] ; Alberto,Ocaña ^[4] ; Eitan,Amir ^[5] ; Arnoud J,Templeton ^[6]

作者单位： Faculty of Medicine, University of Basel, Basel, Switzerland. ^[1] Oncology Department, Departament de Medicina de la Universitat Autònoma de Barcelona, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, Barcelona, Spain. ^[2] Institute of Oncology Ljubljana and Faculty of Medicine, Department of Medical Oncology, University of Ljubljana, Ljubljana, Slovenia. ^[3] Experimental Therapeutics Unit, Medical Oncology Department, Hospital Clínico Universitario San Carlos and IdISSC, Madrid, Spain. ^[4] Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Center and the University of Toronto, Toronto, ON, Canada. ^[5] Faculty of Medicine, University of Basel, Basel, Switzerland.;Department of Medical Oncology, St. Claraspital, Basel, Switzerland.;St. Clara Research Ltd., Basel, Switzerland. ^[6]

医学主题词抗肿瘤药(Antineoplastic Agents);人类(Humans);医学肿瘤学(Medical Oncology);肿瘤(Neoplasms);生活质量(Quality of Life);瑞士(Switzerland)

DOI 10.1371/journal.pone.0268545

PMID 35687539

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交